1186608-83-2 Usage
Description
3-Bromo-5-nitro-1H-pyrazole, a pyrazole derivative with the molecular formula C3H3BrN3O2, is a chemical compound featuring a bromine atom and a nitro group attached to the pyrazole ring. It is recognized for its potential applications in pharmaceuticals, agrochemicals, materials science, and as a reagent in organic synthesis, making it a versatile building block for the synthesis of biologically active compounds.
Uses
Used in Pharmaceutical Industry:
3-Bromo-5-nitro-1H-pyrazole is used as a building block for the synthesis of various biologically active compounds, contributing to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical field, 3-Bromo-5-nitro-1H-pyrazole serves as a key component in the creation of pesticides and other agrochemical products, enhancing crop protection and yield.
Used in Materials Science:
3-Bromo-5-nitro-1H-pyrazole is utilized as a reagent in organic synthesis, playing a role in the development of new materials with specific properties for various applications in science and industry.
Used in Research and Development:
This chemical compound is also used in research for its potential anti-inflammatory and analgesic properties, indicating its possible use in the development of medications for pain relief and inflammation management.
Check Digit Verification of cas no
The CAS Registry Mumber 1186608-83-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,8,6,6,0 and 8 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1186608-83:
(9*1)+(8*1)+(7*8)+(6*6)+(5*6)+(4*0)+(3*8)+(2*8)+(1*3)=182
182 % 10 = 2
So 1186608-83-2 is a valid CAS Registry Number.
1186608-83-2Relevant articles and documents
FIVE-AND-SIX-MEMBERED HETEROCYCLIC COMPOUND AND USE THEREOF AS PROTEIN RECEPTOR KINASE INHIBITOR
-
Paragraph 0060; 0067-0068, (2021/12/18)
A class of five-membered fused with six-membered heterocyclic compounds represented by formula I and a pharmaceutical composition, preparation, and an application thereof are disclosed. These compounds have TRK kinase inhibitory activity and can treat diseases related to TRK dysfunction.
1H-PYRAZOLO [3, 4-B] PYRIDINE COMPOUNDS FOR INHIBITING RAF KINASE
-
Page/Page column 49, (2011/04/14)
Compounds of Formula I are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers, tautomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed. [FORMULA I]
PYRAZOLE [3, 4-B] PYRIDINE RAF INHIBITORS
-
Page/Page column 87-88, (2009/10/22)
Compounds of Formula I are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers, tautomers, prodrugs and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
